ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 192,42
-0,86%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Shield Therapeutics Plc (STX)

  7. Shield Therapeutics Plc (STX) Actualités

STX Shield Therapeutics Plc

1,35
0,125 (10,20%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Shield Therapeutics Plc STX London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,125 10,20% 1,35 17:20:04
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,225 1,20 1,35 1,35 1,225
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
16/4/202408:00UK RNSShield Therapeutics PLC Notice of Results
21/2/202413:36ALNCNewsShield Therapeutics sinks as strong performance marred by..
21/2/202408:00UK RNSShield Therapeutics PLC Unaudited Full Year Trading Update
09/1/202412:33ALNCNewsIN BRIEF: Shield Therapeutics hires former Akili leader as..
09/1/202408:00UKREGShield Therapeutics PLC Appointment of new Chief Financial..
07/12/202316:31ALNCNewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins..
07/12/202308:00UKREGShield Therapeutics PLC Q3 2023 U.S. Commercial Highlights
27/11/202318:24UKREGShield Therapeutics PLC PDMR Transaction Notification
20/10/202312:45RNSNONShield Therapeutics PLC Abstract to be presented at..
12/10/202312:14ALNCNewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf..
12/10/202308:00UKREGShield Therapeutics PLC Chief Financial Officer Transition
03/10/202318:14ALNCNewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's..
03/10/202316:00UKREGShield Therapeutics PLC Result of REX Retail Offer
03/10/202315:29ALNCNewsShield Therapeutics completes USD20 million SWK financing
03/10/202308:00UKREGShield Therapeutics PLC Completion of SWK Financing
03/10/202308:00UKREGShield Therapeutics PLC Block listing Interim Return
28/9/202315:54ALNCNewsUPDATE: Shield Therapeutics completes GBP5 million share..
28/9/202313:50UKREGShield Therapeutics PLC Successful completion of US$6.1m..
28/9/202312:30ALNCNewsShield Therapeutics raises funds for US sales push as loss..
28/9/202308:02UKREGShield Therapeutics PLC REX Retail Offer
28/9/202308:01UKREGShield Therapeutics PLC $20m secured debt facility &proposed..
28/9/202308:00UKREGShield Therapeutics PLC Interim results update and business..
06/9/202321:33ALNCNewsIN BRIEF: Shield Therapeutics changes reporting currency to..
06/9/202308:00UKREGShield Therapeutics PLC Notice of Results and Change in..
06/8/202318:07ALNCNewsCORRECT: Biogens, Sage Therapeutics postpartum depression..
06/8/202315:17ALNCNewsBiogens, Sage Therapeutics postpartum depression treatment..
24/7/202315:27UKREGShield Therapeutics PLC Holding(s) in Company
20/7/202312:43ALNCNewsIN BRIEF: Shield Therapeutics prescription orders up in..
20/7/202308:00UKREGShield Therapeutics PLC Business Update and U.S. Q2 2023..
28/6/202318:30UKREGShield Therapeutics PLC Results of 2023 Annual General..
16/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
15/6/202317:35UKREGAOP Health International Management Lapse of Offer
15/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
15/6/202308:00UKREGAOP Health International Management Acceptance Level Update
14/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
14/6/202308:00UKREGAOP Health International Management Acceptance Level Update
13/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
13/6/202308:00UKREGAOP Health International Management Acceptance Level Update
12/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
12/6/202308:00UKREGAOP Health International Management Acceptance Level Update
09/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
09/6/202308:00UKREGAOP Health International Management Acceptance Level Update
08/6/202313:31UKREGAlbemarle Life Sciences LLP Form 8.3 - Shield Therapeutics..
08/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
08/6/202308:00UKREGAOP Health International Management Acceptance Level Update
07/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
06/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
06/6/202311:10UKREGShield Therapeutics PLC Grant of share options to the CEO
05/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
02/6/202313:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc

Dernières Valeurs Consultées

LSE
STX
Shield Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés